Clinical trials
Phase 2 Glioma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2011 | 2 |
| 2017 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Celgene | 1 |
| Fore Biotherapeutics | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Corporation | 1 |
| Nationwide Children's Hospital | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| Rigel Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 13 |
| Brain Neoplasms | 6 |
| Glioblastoma | 6 |
| Oligodendroglioma | 6 |
| Astrocytoma | 5 |
| Central Nervous System Neoplasms | 5 |
| Diffuse Intrinsic Pontine Glioma | 2 |
| Ependymoma | 2 |
| Gliosarcoma | 2 |
| Medulloblastoma | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.